NEOLEV3: A Phase IIb Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures of Mild to Moderate Severity IND-109622 (September 6, 2020)
|Effective start/end date||9/20/22 → 8/31/26|
- DHHS FOOD & DRUG ADMINISTRATION (FDA)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.